Effectiveness of transpore tape versus transparent film dressing on detecting early state of phlebitis: a randomized control trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

TCTR

Registry ID

TCTR20210801004

Enrollment

308

Registered

2021-08-01

Start date

2020-11-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early state of phlebitis phlebitis

Interventions

A transparent film dressing was used to secure the catheter inserted into the patient in the transparent film dressing group.

Experimental Device

The transparent film dressing

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: The inclusion criteria include the individuals who - were adult patients, who are over 18 years old, - were body mass index (BMI) between 18.5-22.90 kg/m2, - received IV therapy with osmolality < 820 mOsm/L through PIVC during hospitalization, - were cooperative, communicative, and willing to participate in this study

Exclusion criteria

Exclusion criteria: The exclusion criteria include patients receiving immunosuppressive therapy, patient with hypercoagulability, diaphoretic, peripheral nervous system disorders, and allergic contact dermatitis to transparent dressings.

Design outcomes

Primary

Measure	Time frame
Early state of phlebitis at least every eight hours Observation	—

Secondary

Measure	Time frame
N/A N/A N/A	—

Countries

Thailand

Contacts

Public ContactPramote Thangkratok

Srisavarindhira Thai Red Cross Institute of Nursing

pramot_computer@hotmail.com0843761058

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026